FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Nirogacestat is approved by the FDA for treating rare non-cancerous soft tissue sarcomas.

2.

Three-Drug Regimens Make Case for a Role in Untreated and Relapsed/Refractory CLL

3.

Transplantation Fails to Improve Survival in Mantle Cell Lymphoma

4.

WHO launches plan for free child cancer medicines

5.

Gene therapy and chemotherapy may be combined in novel ways to treat bone cancer.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot